JSPR - Jasper Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

JSPR is currently covered by 3 analysts with an average price target of $5.33. This is a potential downside of $3.36 (-38.67%) from yesterday's end of day stock price of $8.69.

Jasper Therapeutics's activity chart (see below) currently has 53 price targets and 76 ratings on display. The stock rating distribution of JSPR is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 24.4% of the time, taking 169.62 days on average.

Highest price target for JSPR is $7, Lowest price target is $3, average price target is $5.33.

Most recent stock forecast was given by SILVAN TUERKCAN from JMP on 18-May-2026. First documented stock forecast 12-Oct-2021.

Currently out of the existing stock ratings of JSPR, 4 are a BUY (80%), 1 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Sep-2024

$6

$-2.69 (-30.96%)

$6

6 months 3 days ago
(18-May-2026)

5/9 (55.56%)

$5.19 (640.74%)

314

Hold Since 10-Nov-2025

$3

$-5.69 (-65.48%)

$4

6 months 6 days ago
(15-May-2026)

2/2 (100%)

$2.15 (252.94%)

264

Buy Since 03-Apr-2024

$7

$-1.69 (-19.45%)

7 months 20 days ago
(01-Apr-2026)

1/4 (25%)

$6.2 (775.00%)

215

Buy Since 08-Jul-2024

$7

$20

1 years 2 months 2 days ago
(19-Sep-2025)

1/5 (20%)

$4.5 (180.00%)

409

Buy Since 27-Mar-2024

$5

$46

1 years 4 months 13 days ago
(08-Jul-2025)

1/6 (16.67%)

$1.98 (65.56%)

482

Show more analysts

Please expand the browser size to see the chart

What is JSPR (Jasper Therapeutics) average time for price targets to be met?

On average it took 170 days for the stock forecasts to be reached, with an average price target met ratio of 24.4%.

Which analyst most recently updated their price target on JSPR (Jasper Therapeutics)?

Silvan Tuerkcan

Which analyst has the most public recommendations on JSPR (Jasper Therapeutics)?

Silvan Tuerkcan works at JMP and has 5 price targets and 13 ratings on JSPR

Which analyst is the currently most bullish on JSPR (Jasper Therapeutics)?

Matthew Luchini with the highest potential upside of $1898.95

Which analyst is the currently most reserved on JSPR (Jasper Therapeutics)?

Leonid Timashev with the lowest potential downside of -$5.69
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?